Amalgamated Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-353
| Closed | -$5K | – | 3182 |
|
2024
Q1 | $5K | Sell |
353
-1,129
| -76% | -$16K | ﹤0.01% | 2757 |
|
2023
Q4 | $20K | Sell |
1,482
-105
| -7% | -$1.42K | ﹤0.01% | 2660 |
|
2023
Q3 | $20K | Hold |
1,587
| – | – | ﹤0.01% | 2669 |
|
2023
Q2 | $20K | Buy |
+1,587
| New | +$20K | ﹤0.01% | 2755 |
|
2017
Q3 | – | Sell |
-2,091
| Closed | -$20K | – | 1619 |
|
2017
Q2 | $20K | Buy |
2,091
+170
| +9% | +$1.63K | ﹤0.01% | 1581 |
|
2017
Q1 | $47K | Buy |
1,921
+1
| +0.1% | +$24 | ﹤0.01% | 1472 |
|
2016
Q4 | $62K | Buy |
1,920
+254
| +15% | +$8.2K | ﹤0.01% | 1475 |
|
2016
Q3 | $83K | Buy |
1,666
+7
| +0.4% | +$349 | ﹤0.01% | 1346 |
|
2016
Q2 | $67K | Buy |
1,659
+108
| +7% | +$4.36K | ﹤0.01% | 1348 |
|
2016
Q1 | $102K | Buy |
1,551
+150
| +11% | +$9.87K | 0.01% | 1221 |
|
2015
Q4 | $87K | Sell |
1,401
-69
| -5% | -$4.29K | 0.01% | 1151 |
|
2015
Q3 | $98K | Buy |
1,470
+23
| +2% | +$1.53K | 0.01% | 1241 |
|
2015
Q2 | $141K | Buy |
+1,447
| New | +$141K | 0.01% | 1287 |
|
2014
Q1 | – | Sell |
-1,275
| Closed | -$54K | – | 863 |
|
2013
Q4 | $54K | Buy |
+1,275
| New | +$54K | 0.01% | 818 |
|